Immunai Company
Immunai is a biotech company that combines single cell genomics with ML algorithms to enable high resolution profiling of the immune system.
Investors
Last Funding Type:
Series B
Funding Status:
Early Stage Venture
Headquarters:
New York, New York, United States
Founded Date:
2018-12-01
Investor Type:
info@immunai.com
Last Funding Date:
2021-10-27
Total Funding:
295000000.0
Technology:
Artificial Intelligence, Biotechnology, Machine Learning, Therapeutics
Employee Number:
101-250
Acquisitions Number:
2
Investors Number:
13.0
Industry:
Medical BioTech